Item 7.01 Regulation FD Disclosure. On June 1, 2026, Keros Therapeutics, Inc. (the “Company”) issued a press release announcing that Jasbir Seehra, the Company’s President and Chief Executive Officer, will participate in a fireside chat presentation at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. Eastern time. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.
KROS Keros Therapeutics, Inc. - 8-K
Accession
0001664710-26-0000327.019.01
Item 7.01 - Regulation FD Disclosure
190 words
Item 9.01 - Financial Statements and Exhibits
37 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated June 1 , 2026. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)